<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.34215/1609-1175-2020-4-76-80</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-2129</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Неспецифические поражения кожи при злокачественных лимфомах</article-title><trans-title-group xml:lang="en"><trans-title>Nonspecific skin lesions in malignant lymphomas</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7598-5586</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рукавицын</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Rukavitsyn</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач консультативно-диагностического отделения,</p><p>192102, г. Санкт-Петербург, наб. реки Волковки, 3</p></bio><bio xml:lang="en"><p>MD, </p><p>3 river Volkovka emb., Saint-Petersburg, 192102</p></bio><email xlink:type="simple">rukcyn@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7707-441X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ламоткин</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lamotkin</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, начальник дерматовенерологического отделения,</p><p>105229, г. Москва, Госпитальная пл. 3</p></bio><bio xml:lang="en"><p>MD, PhD, professor, head of the Dermatovenerological Department, </p><p>3 Gospitalnaya Sq., Moscow, 105229</p></bio><email xlink:type="simple">ilamotkin@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1309-7265</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рукавицын</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rukavitsyn</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, начальник гематологического центра,</p><p>105229, г. Москва, Госпитальная пл. 3</p></bio><bio xml:lang="en"><p>MD, PhD, professor, head of the Hematology Center, </p><p>3 Gospitalnaya Sq., Moscow, 105229</p></bio><email xlink:type="simple">ngc@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ламоткин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Lamotkin</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>студент учебного военного центра лечебного факультета,</p><p>119992, г. Москва, ул. Трубецкая, 8/2</p></bio><bio xml:lang="en"><p>student, </p><p>8/2 Trubetskaya St., Moscow, 119992</p></bio><email xlink:type="simple">lamotkin.an@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Городской кожно-венерологический диспансер</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint-Petersburg City Dermatovenerologic Dispensary</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Главный военный клинический госпиталь им. Н.Н. Бурденко</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Burdenko Main Military Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет им. И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2020</year></pub-date><volume>0</volume><issue>4</issue><fpage>76</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рукавицын А.О., Ламоткин И.А., Рукавицын О.А., Ламоткин А.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Рукавицын А.О., Ламоткин И.А., Рукавицын О.А., Ламоткин А.И.</copyright-holder><copyright-holder xml:lang="en">Rukavitsyn A.O., Lamotkin I.A., Rukavitsyn O.A., Lamotkin A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/2129">https://www.tmj-vgmu.ru/jour/article/view/2129</self-uri><abstract><sec><title>Цель</title><p>Цель: клиническая характеристика особенностей неспецифических поражений кожи при злокачественных лимфомах (ЗЛ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Наблюдали 130 пациентов со злокачественными лимфомами: лимфомой Ходжкина – 50 человек, В-клеточными лимфомами – 38 человек и Т-клеточными лимфомами – 42 человека.</p></sec><sec><title>Результаты</title><p>Результаты. Выделено шесть основных типов неспецифического поражения кожных покровов у больных ЗЛ: 1) поражения кожи аутотоксического генеза, 2) поражения кожи, обусловленные сосудистой патологией, 3) поражения кожи из-за гемолиза и гемостатических нарушений, 4) поражения кожи при криоглобулинемии/криофибриногенемии, 5) поражения кожи из-за нарушений обмена веществ, 6) инфекционные поражения.</p></sec><sec><title>Заключение</title><p>Заключение. Среди неспецифических изменений кожного покрова при ЗЛ преобладают поражения аутотоксического генеза и инфекционные поражения. При лимфоме Ходжкина чаще встречается кожный зуд. Среди В-клеточных лимфом кожные поражения более патогномоничны для хронического лимфолейкоза, а среди Т-клеточных лимфом – для грибовидного микоза. Неспецифические поражения кожи, возникшие до появления типичной клинической картины ЗЛ, позволяют заподозрить и вовремя диагностировать основное заболевание. Исчезновение кожных поражений на фоне специфической терапии может свидетельствовать об эффективности лечения ЗЛ. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: Clinical characteristics of the peculiarities of non-specific skin lesions with patients having malignant lymphomas (ML).</p></sec><sec><title>Methods</title><p>Methods: 130 patients having malignant lymphomas were observed, 50 patients – having Hodgkin’s lymphomas, 38 patients - B-cell lymphomas and 42 patients – T-cell lymphomas.</p></sec><sec><title>Results</title><p>Results: Six main types of nonspecific lesions are defined among patients having malignant lymphomas: 1) skin lesions of auto toxic genesis, 2) skin lesions determined with vascular pathology, 3) skin lesions due to hemolysis and hemostatic disorders, 4) skin lesions of those having cryoglobulinemia/cryofibrinogenemia, 5) skin lesions due to metabolic disorder, 6) infectious diseases.</p></sec><sec><title>Conclusions</title><p>Conclusions: Lesions of auto toxic genesis and infectious diseases prevail among nonspecific skin changes when having malignant lymphomas. Patients having Hodgkin’s lymphomas experience dermal itching more often. Among B-cell lymphomas skin lesions are more pathognomonic for chronic lymphocytic leukemia, among T-cell lymphomas – for fungal mycosis. Nonspecific skin lesions, having arisen before typical clinical picture of malignant lymphomas allow to suspect and diagnose the main illness on time. Disappearance of skin lesions against the background of specific therapy can bear evidence to the efficiency of the malignant lymphomas’ treatment. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Ходжкина</kwd><kwd>В-клеточные лимфомы</kwd><kwd>Т-клеточные лимфомы</kwd><kwd>паранеоплазии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Hodgkin’s disease</kwd><kwd>B-cell lymphomas</kwd><kwd>T-cell lymphomas</kwd><kwd>paraneoplasia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mandal S, Varma K, Jain S. Cutaneous manifestations in nonHodgkin’s lymphoma. Acta Cytol. 2007;51:853–9.</mixed-citation><mixed-citation xml:lang="en">Mandal S, Varma K, Jain S. Cutaneous manifestations in nonHodgkin’s lymphoma. Acta Cytol. 2007;51:853–9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ламоткин И.А., Рукавицын А.О., Кристостурова О.В. Паранеопластический кожный зуд при лимфопролиферативных заболеваниях. Военно-медицинский журнал. 2016;337(9):59– 60.</mixed-citation><mixed-citation xml:lang="en">Lamotkin IA, Rukavitsyn AO, Kristosturova OV. Paraneoplastic skin itch in case of lymphoproliterative diseases. VoennoMeditsinsky Zhurnal. 2016;337(9):59–60 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ламоткин И.А. Онкодерматология: атлас. М.: Лаборатория знаний, 2017.</mixed-citation><mixed-citation xml:lang="en">Lamotkin IA. Oncodermatology: Atlas. Moscow: Laboratoriya Znaniy; 2017 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Swerdlow SH. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: IARC; 2017.</mixed-citation><mixed-citation xml:lang="en">Swerdlow SH. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: IARC; 2017.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–14.</mixed-citation><mixed-citation xml:lang="en">Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–14.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rowe B, Yosipovitch G. Malignancy-associated pruritus. Eur J Pain. 2016;20(1):19–23.</mixed-citation><mixed-citation xml:lang="en">Rowe B, Yosipovitch G. Malignancy-associated pruritus. Eur J Pain. 2016;20(1):19–23.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yosipovitch G. Chonic pruritus: A paraneoplastic sign. Derm Therap. 2010;23:590–6</mixed-citation><mixed-citation xml:lang="en">Yosipovitch G. Chonic pruritus: A paraneoplastic sign. Derm Therap. 2010;23:590–6</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Адаскевич В.П. Кожный зуд. Дерматологический и междисциплинарный феномен. М.: Изд-во Панфилова; БИНОМ, 2014.</mixed-citation><mixed-citation xml:lang="en">Adaskevich VP. Itching. Dermatological and interdisciplinary phenomenon. Moscow: Izdatelstvo Panfilova; BINOM; 2014 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vu J, Ho J, English JC. Dermal hypersensitivity reaction as a prodrome to Hodgkin lymphoma. J Am Acad Dermatol. 2010;63(1):13–14.</mixed-citation><mixed-citation xml:lang="en">Vu J, Ho J, English JC. Dermal hypersensitivity reaction as a prodrome to Hodgkin lymphoma. J Am Acad Dermatol. 2010;63(1):13–14.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tomlinson R, Yaxley J. Thrombotic thrombocytopenic purpura associated with Hodgkin lymphoma and non-Hodgkin lymphoma. Pathology. 2018;50(7):776–7.</mixed-citation><mixed-citation xml:lang="en">Tomlinson R, Yaxley J. Thrombotic thrombocytopenic purpura associated with Hodgkin lymphoma and non-Hodgkin lymphoma. Pathology. 2018;50(7):776–7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Заславский Д.В., Родионов А.Н., Чупров И.Н., Насыров Р.А., Егорова Ю.С., Сыдиков А.А. Эволюция взглядов на эритродермию. Российский журнал кожных и венерических болезней. 2017;20(1):10–14.</mixed-citation><mixed-citation xml:lang="en">Zaslavsky DV, Rodionov AN, Chuprov IN, Nasyrov RA, Egorova YuS, Sidikov AA. The evolution of views on the erythroderma. Russian Journal of Skin and Venereal Diseases. 2017;20(1):10–14 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Carlesimo M, Narcisi A, Rossi A, Saredi I, Orsini D, Pelliccia S, et al. Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): Study and review of literature. J Eur Acad Dermatol Venereol. 2014;28(2):133–41.</mixed-citation><mixed-citation xml:lang="en">Carlesimo M, Narcisi A, Rossi A, Saredi I, Orsini D, Pelliccia S, et al. Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): Study and review of literature. J Eur Acad Dermatol Venereol. 2014;28(2):133–41.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Муравьева Е.А., Олисова О.Ю., Никитин Е.А. Поражения кожи при хроническом лимфолейкозе. Российский журнал кожных и венерических болезней. 2013;6:4–9.</mixed-citation><mixed-citation xml:lang="en">Muravyova EA, Olisova OYu, Nikitin EA. Skin involvement in chronic lymphoid leukemia. Russian Journal of Skin and Venereal Diseases. 2013;6:4–9 (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Miladi A, Thomas BC, Beasley K, Meyerle J. Angioimmunoblastic T-cell lymphoma presenting as purpura fulminans. Cutis. 2015;95(2):113–5.</mixed-citation><mixed-citation xml:lang="en">Miladi A, Thomas BC, Beasley K, Meyerle J. Angioimmunoblastic T-cell lymphoma presenting as purpura fulminans. Cutis. 2015;95(2):113–5.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
